Suraksha Diagnostic vs Peers
- Market cap
- ₹1,625 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹224.68 – ₹421.27
Suraksha Diagnostic ranks 1st by market capitalisation among 1 Diagnostics & Research companies tracked by ATS. Its largest peers are Suraksha Diagnostic. Its P/E of 22.5 compares with a peer median of 22.5.
Suraksha Diagnostic vs Diagnostics & Research peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic | 312.05 | -3.00% | 1,625 | 22.5 | 2.85 | 14.5% | +18.5% |
| Suraksha Diagnostic | 312.05 | -3.00% | 1,625 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Suraksha Diagnostic peer comparison — frequently asked questions
Who are Suraksha Diagnostic's competitors?
Suraksha Diagnostic's listed peers in Diagnostics & Research include Suraksha Diagnostic, ranked here by market capitalisation.
How does Suraksha Diagnostic's P/E compare with its peers?
Suraksha Diagnostic trades at a P/E of 22.5, against a median of 22.5 across the 1 Diagnostics & Research peers shown.
Which is the largest company among Suraksha Diagnostic's peers?
By market capitalisation, the largest company in the group is Suraksha Diagnostic at ₹1,625 crore, against ₹1,625 crore for Suraksha Diagnostic.
Same Data For Peers
Trade Suraksha Diagnostic With ATS
Track SURAKSHA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.